AI Insight
This commentary discusses a breakthrough case where a genetically engineered porcine kidney successfully supported a living human recipient for 271 days without dialysis, representing the longest functioning kidney xenograft reported to date. The patient subsequently received a human kidney transplant after the porcine kidney was removed. This achievement marks significant progress in the field of xenotransplantation, which has rapidly advanced from laboratory models to deceased recipients to living patients over the past three years.
Why it matters
The success of this xenotransplant addresses the critical shortage of human kidneys for transplantation, which currently results in many patients dying while waiting for organs. Genetically engineered porcine kidneys could potentially expand the donor pool and serve either as temporary bridges to human transplantation or eventually as permanent treatment options for patients with kidney failure.
Understand the Science
The shortage of human kidneys remains a central problem in transplantation, and many candidates die or are removed from the waiting list before an organ becomes available.1 Genetically engineered porcine kidneys have long been proposed to expand the donor pool,2 and over the past 3 years the field has rapidly moved from preclinical models to decedent models to living recipients.3–5 In their Article, Leonardo Riella and colleagues report a porcine kidney xenograft that supported a living human recipient for 271 days—the longest dialysis-free xenograft function described to date—followed by explantation and a subsequent deceased-donor human kidney transplantation.
Source: [Comment] Kidney xenotransplantation—bridge to allotransplantation or destination treatment?